| Application: | Internal Medicine |
|---|---|
| Usage Mode: | for Injection |
| Suitable for: | Elderly, Children, Adult |
| State: | Liquid |
| Shape: | for Injection |
| Type: | Biological Products |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
Indications:
Amikacin is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species. Although amikacin is not the drug of choice for infections due to staphylococci, at times it may be indicated for the treatment of known or suspected staphylococcal disease. These situations include: the initiation of therapy for severe infections when the organisms suspected are either Gram-negative or staphylococci, patients allergic to other antibiotics, and mixed staphylococcal/Gram-negative infections.
Dosage and Administration:
Amikacin sulphate injection may be given intramuscularly or intravenously.
Amikacin should not be physically premixed with other drugs, but should be administered separately according to the recommended dose and route.
The patient's pre-treatment bodyweight should be obtained for calculation of correct dosage.
For most infections the intramuscular route is preferred, but in life-threatening infections, or in patients in whom intramuscular injection is not feasible, the intravenous route, either slow bolus or infusion may be used.
Storage instructions:
Do not store above 25°C.
| Testing terms | Standards | Results |
| Shape | Colorless to light yellow clear liquid | Colorless clear liquid |
| PH | 3.5~5.5 | 4.7 |
| Kanamycin | <=2% | Not detected |
| Bacterial endomycin | <0.33EU | Conformity |
| Loading difference | Comply with the standard | Conformity |
| Microbial Limit | Comply with the standard | Conformity |
| Assay | 90.0%-110.0% | 100.0% |
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}